Michael W. A. Chu, MD, Steve R. Wilson, BS, Richard J

Slides:

Advertisements

Similar presentations

Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting

Advertisements

Squamous Cell Carcinoma of the Pericardium Found During Coronary Bypass Surgery of Possible Cutaneous Origin Alan P. Kypson, MD, Curtis A. Anderson,

Benefits and risks of using clopidogrel before coronary artery bypass surgery: Systematic review and meta-analysis of randomized trials and observational.

Major Bleeding, Transfusions, and Anemia: The Deadly Triad of Cardiac Surgery Marco Ranucci, MD, FESC, Ekaterina Baryshnikova, BD, Serenella Castelvecchio,

Effect of Hospital Culture on Blood Transfusion in Cardiac Procedures

Bilateral Internal Mammary Artery Use for Coronary Artery Bypass Grafting Remains Underutilized: A Propensity-Matched Multi-Institution Analysis Damien.

Contemporary Bloodletting in Cardiac Surgical Care

Warfarin therapy does not increase bleeding in patients undergoing heart transplantation Cullen D Morris, MD, J.David Vega, MD, Jerrold H Levy, MD, Nancy.

Amit Iyengar, Christopher N. Scipione, MD, Parth Sheth, Richard G

Implementation of a comprehensive blood conservation program can reduce blood use in a community cardiac surgery program Steve Xydas, MD, Christopher.

Robert Brewer, MD, MHSA, Patricia F. Theurer, BSN, Chad M

Gaetano Paone, MD, MHSA, Robert Brewer, MD, MHSA, Donald S

Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations: A prospective randomized study Raimondo Ascione,

Off-pump epicardial tissue sealing—a novel method for atrioventricular disruption complicating mitral valve procedures Albert Schuetz, MD, PhD, Costas.

Coronary Artery Revascularization (CARE) Registry: An Observational Study of On- Pump and Off-Pump Coronary Artery Revascularization George Palmer, MD,

Age of Transfused Red Cells and Early Outcomes After Cardiac Surgery

Atrial Fibrillation After Coronary Artery Bypass Grafting Surgery: Development of a Predictive Risk Algorithm Mitchell J. Magee, MD, Morley A. Herbert,

Robert E. Freundlich, MD, MS, Michael D. Maile, MD, MS, Mark M

Coronary artery operation in patients after breast cancer therapy

Theodore C Koutlas, MD, Joseph R Elbeery, MD, J

Emergency Coronary Artery Bypass Grafting Can Be Performed Safely Without Cardiopulmonary Bypass in Selected Patients Faraz Kerendi, MD, John D. Puskas,

Chronic Atrial Fibrillation Is Associated With Reduced Survival After Aortic and Double Valve Replacement Richard Schulenberg, MD, Polychronis Antonitsis,

Robotic-Assisted Coronary Artery Bypass on a Beating Heart: Initial Experience and Implications for the Future William F. Turner, MD, John H. Sloan,

Glucose-Insulin-Potassium in Cardiac Surgery: A Meta-Analysis

Surgical Resection of a Giant Coronary Aneurysm

Susanne Lison, MD, Michael Spannagl, MD, PhD, Wulf Dietrich, MD, PhD

Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis Timothy S. Lancaster,

Performing Coronary Artery Bypass Grafting Off-Pump May Compromise Long-Term Survival in a Veteran Population Faisal G. Bakaeen, MD, Danny Chu, MD, Rosemary.

Richard S. D’Agostino, MD, Jeffrey P

Preoperative Intraaortic Balloon Pump for Off-Pump Coronary Arterial Revascularization Vito Mannacio, MD, Luigi Di Tommaso, MD, Vincenzo De Amicis, MD,

Mariano E. Brizzio, MD, Alex Zapolanski, MD, Richard E

Use of Recombinant Activated Factor VII Concentrate to Control Postoperative Hemorrhage in Complex Cardiovascular Surgery Lyndsey J. Bowman, Walter E.

Risks and Predictors of Blood Transfusion in Pediatric Patients Undergoing Open Heart Operations Andrea Székely, MD, PhD, Zsuzsanna Cserép, MD, Erzsébet.

Optimal Plasma Transfusion in Patients Undergoing Cardiac Operations With Massive Transfusion Michael A. Mazzeffi, MD, MPH, Evan Chriss, MD, Kathryn.

Anomalous Origin of Left Pulmonary Artery From Left Subclavian Artery

Zoe K. McQuilten, MBBS, Nick Andrianopoulos, MBBS, MBiostat, Erica M

Safety and efficacy of perioperative cell salvage and autotransfusion after coronary artery bypass grafting: a randomized trial Gavin J Murphy, MD, FRCS,

Coronary surgery without cardiotomy suction and autotransfusion reduces the postoperative systemic inflammatory response Martin Westerberg, MD, Anders.

Joshua W. Salvin, MD, MPH, Mark A. Scheurer, MD, Peter C

Pathology of the Radial and Internal Thoracic Arteries Used as Coronary Artery Bypass Grafts Eric Kaufer, BS, Stephen M Factor, MD, Rosemary Frame, MS,

Effect of Hospital Culture on Blood Transfusion in Cardiac Procedures

Benjamin C. Sun, MD, Timothy A. Dickinson, CCP, Eric A

Predictors of massive transfusion with thoracic aortic procedures involving deep hypothermic circulatory arrest Judson B. Williams, MD, Barbara Phillips-Bute,

Editorial Board, January 2010

Association between postoperative hypothermia and adverse outcome after coronary artery bypass surgery Steven R Insler, Michael S O’Connor, Marvin J.

Coronary endarterectomy with off-pump coronary artery bypass surgery

Red Blood Cell Transfusion Is Associated With Troponin Release After Elective Off- Pump Coronary Artery Bypass Surgery Fausto Biancari, MD, PhD, Eeva-Maija.

Statin in Combination With β-Blocker Therapy Reduces Postoperative Stroke After Coronary Artery Bypass Graft Surgery Denis Bouchard, MD, Michel Carrier,

Assessment of the Association of Bilateral Internal Thoracic Artery Skeletonization and Sternal Wound Infection After Coronary Artery Bypass Grafting

Limitations of Hospital Volume as a Measure of Quality of Care for Coronary Artery Bypass Graft Surgery Karl F. Welke, MD, Mitchell J. Barnett, PharmD,

Association of bacterial infection and red blood cell transfusion after coronary artery bypass surgery Scott B Chelemer, MD, B.Stephen Prato, MA, Paul.

Use of recombinant factor VIIa as a rescue treatment for intractable bleeding following repeat aortic arch repair Greg Stratmann, MD, PhD, Isobel A Russell,

Minimal access aortic valve replacement: effects on morbidity and resource utilization Nicolas Doll, MD, Michael A Borger, MD, PhD, Joerg Hain, Jan Bucerius,

Bleeding Complications and Blood Product Utilization With Left Ventricular Assist Device Implantation Justin M. Schaffer, MS, George J. Arnaoutakis,

First Report on 30-day and Operative Mortality in Risk Model of Isolated Coronary Artery Bypass Grafting in Japan Noboru Motomura, MD, PhD, Hiroaki Miyata,

Comparison of epsilon aminocaproic acid and low-dose aprotinin in cardiopulmonary bypass: efficiency, safety and cost Michael J Ray, PhD, Mark F O’Brien

Total Arterial Off-Pump Coronary Surgery: Time to Change Our Habits?

Randomized Controlled Trial of Pericardial Blood Processing With a Cell-Saving Device on Neurologic Markers in Elderly Patients Undergoing Coronary Artery.

Red Blood Cell Transfusions Impact Pneumonia Rates After Coronary Artery Bypass Grafting Donald S. Likosky, PhD, Gaetano Paone, MD, MHSA, Min Zhang,

Sérgio A de Oliveira, MD The Annals of Thoracic Surgery

Blood Transfusion and Infection After Cardiac Surgery

Catheter-Based Endoscopic Bypass Grafting: An Experimental Feasibility Study Stephan Jacobs, MD, David Holzhey, MD, Hubert Stein, BS, BME, Friedrich W.

Potassium and Magnesium Supplementation Do Not Protect Against Atrial Fibrillation After Cardiac Operation: A Time-Matched Analysis Timothy S. Lancaster,

Severe Coronary Artery Disease With Coarctation of the Aorta: Role of Off-Pump Coronary Artery Bypass Grafting Komarakshi R. Balakrishnan, MD, Sadagopan.

Increased Rehospitalization Rate After Coronary Bypass Operation for Acute Coronary Syndrome: A Prospective Study in 200 Patients Staffan Bjessmo, MD,

Dumbor L. Ngaage, MD, FRCS (C-Th), Michael E. Cowen, FRCS

Slide Tracheoplasty in Infants and Children: Risk Factors for Prolonged Postoperative Ventilatory Support Peter B. Manning, MD, Michael J. Rutter, MD,

Leukocytosis and Increased Risk of Atrial Fibrillation After General Thoracic Surgery David Amar, MD, Anuj Goenka, BS, Hao Zhang, MD, Bernard Park, MD,

Karl A. Bocchieri, BS, CCP, S. Jacob Scheinerman, MD, L

Harvey Edward Garrett, MD, Bradley A. Wolf, MD

Presentation transcript:

Does Clopidogrel Increase Blood Loss Following Coronary Artery Bypass Surgery? Michael W.A. Chu, MD, Steve R. Wilson, BS, Richard J. Novick, MD, Larry W. Stitt, MS, MacKenzie A. Quantz, MD The Annals of Thoracic Surgery Volume 78, Issue 5, Pages 1536-1541 (November 2004) DOI: 10.1016/j.athoracsur.2004.03.028

Fig 1 First 24 hour blood losses postoperatively (mean values with standard deviation). Black bar = clopidogrel 0 to 4 days; thatched bar = clopidogrel 5 to 8 days; white bar = no clopidogrel. The Annals of Thoracic Surgery 2004 78, 1536-1541DOI: (10.1016/j.athoracsur.2004.03.028)

Fig 2 Postoperative transfusion requirements. Black bar = clopidogrel 0 to 4 days; thatched bar = clopidogrel 5 to 8 days; white bar = no clopidogrel. (cryo = cryoprecipitate; FFP = fresh frozen plasma; pRBC = packed red blood cells.) The Annals of Thoracic Surgery 2004 78, 1536-1541DOI: (10.1016/j.athoracsur.2004.03.028)